COVID-19 vaccination coverage in the EU/EEA during the 2023–24 season campaigns

Surveillance and monitoring
Cite:

European Centre for Disease Prevention and Control. COVID-19 vaccination coverage in the EU/EEA during the 2023–24 season campaigns. Stockholm: ECDC; 2024.

This report presents a description of COVID-19 vaccine coverage in the European Union/European Economic Area (EU/EEA) between 1 September 2023 and 31 July 2024.

Key facts

  • In September 2023, ECDC updated its COVID-19 vaccination coverage data analysis process, in view of the evolving timing and objective of the 2023–24 season vaccination campaigns. This report presents a description of COVID-19 vaccine coverage in the European Union/European Economic Area (EU/EEA) between 1 September 2023 and 31 July 2024.
  • During the reporting period, 28/30 EU/EEA countries reported data on COVID-19 vaccination coverage for at least one target group (people aged 60 years and above, people aged 80 years and above, healthcare workers, individuals with chronic conditions, or pregnant women).
  • During this period, approximately 28.7 million people aged 60 years and above received one COVID-19 vaccine dose. Approximately 7.3 million people aged 80 years and above received one COVID-19 vaccine dose.
  • The median COVID-19 vaccination coverage among people aged 60 years and above was 14.0% (range: 0.02–66.1%), with high variation among countries. For people aged 80 years and above, the median coverage was 21.5% (range: 0.03–93.9%), with high variation among countries.
  • Among the 28 reporting countries, six countries reported a vaccination coverage ≥50% for the age group 60 years and above, while nine countries reported a vaccination coverage ≥50% for the age group 80 years and above.
  • Most of the approximately 31.3 million COVID-19 vaccine doses administered in the EU/EEA during this period in the overall population were the Comirnaty Omicron XBB.1.5 (Pfizer BioNTech) vaccine (around 24 million doses; 76.7% of the total doses administered).